Nimoclav -625

Nimoclav-625 – Committed to Quality Healthcare Solutions

Introducing Nimoclav-625, a trusted formulation of Amoxycillin and Potassium Clavulanate Tablets IP designed to address a wide range of bacterial infections effectively. Backed by rigorous quality standards and scientific expertise, Nimoclav-625 is a reliable choice for healthcare professionals and patients alike. Product Overview

Composition: Amoxycillin & Potassium Clavulanate Tablets IP

Packaging: Available in a convenient 10x1x10 tablet pack.

Manufacturing License Number: MNB/08/713 & MB/08/714

Batch Number: Clearly mentioned for traceability and quality assurance.

Manufacturing and Expiry Date: Ensuring product safety and efficacy within the specified time frame.

MRP (Per 10 Tablets): Inclusive of all applicable taxes for transparency and convenience.

Key Features

Dual Action Formula: The combination of Amoxycillin, a potent antibiotic, and Potassium Clavulanate, a beta-lactamase inhibitor, ensures enhanced effectiveness against resistant bacterial strains.

Broad-Spectrum Coverage: Effective against a variety of bacterial infections, including respiratory tract, urinary tract, and skin infections.

Stringent Quality Standards: Manufactured under strict guidelines to ensure safety, purity, and consistency in every tablet.

At Amparo Health Care, we prioritize delivering safe and effective healthcare solutions. Nimoclav-625 reflects our commitment to combating bacterial infections with precision and reliability. For healthcare professionals and patients seeking a trusted antibiotic solution, Nimoclav-625 is your answer. Empowering health, one tablet at a time.